Glucagon-like peptide-1 receptor analogues in renal transplant recipients with diabetes: Medium term follow of patients from a single UK centre.

Abstract

Diabetic MedicineEarly View e15057 LETTER Glucagon-like peptide-1 receptor analogues in renal transplant recipients with diabetes: Medium term follow of patients from a single UK centre Ritwika Mallik, Ritwika Mallik Department of Diabetes and Metabolism, The Royal London Hospital, London, UKSearch for more papers by this authorOmer Ali, Omer Ali Department of Nephrology, The Royal London Hospital, London, UKSearch for more papers by this authorMahalia Casabar, Mahalia Casabar Department of Nephrology, The Royal London Hospital, London, UKSearch for more papers by this authorDorcas Mukuba, Dorcas Mukuba Department of Diabetes and Metabolism, The Royal London Hospital, London, UKSearch for more papers by this authorConnor Byrne, Connor Byrne Department of Nephrology, The Royal London Hospital, London, UKSearch for more papers by this authorKieran McCafferty, Kieran McCafferty Department of Nephrology, The Royal London Hospital, London, UKSearch for more papers by this authorM. Magdi Yaqoob, M. Magdi Yaqoob Department of Nephrology, The Royal London Hospital, London, UKSearch for more papers by this authorTahseen A. Chowdhury, Corresponding Author Tahseen A. Chowdhury tahseen.chowdhury@nhs.net orcid.org/0000-0001-8878-2331 Department of Diabetes and Metabolism, The Royal London Hospital, London, UK Correspondence Tahseen A. Chowdhury, 7th Floor, John Harrison House. The Royal London Hospital, Whitechapel, London E1 1BB, UK. Email: tahseen.chowdhury@nhs.netSearch for more papers by this author Ritwika Mallik, Ritwika Mallik Department of Diabetes and Metabolism, The Royal London Hospital, London, UKSearch for more papers by this authorOmer Ali, Omer Ali Department of Nephrology, The Royal London Hospital, London, UKSearch for more papers by this authorMahalia Casabar, Mahalia Casabar Department of Nephrology, The Royal London Hospital, London, UKSearch for more papers by this authorDorcas Mukuba, Dorcas Mukuba Department of Diabetes and Metabolism, The Royal London Hospital, London, UKSearch for more papers by this authorConnor Byrne, Connor Byrne Department of Nephrology, The Royal London Hospital, London, UKSearch for more papers by this authorKieran McCafferty, Kieran McCafferty Department of Nephrology, The Royal London Hospital, London, UKSearch for more papers by this authorM. Magdi Yaqoob, M. Magdi Yaqoob Department of Nephrology, The Royal London Hospital, London, UKSearch for more papers by this authorTahseen A. Chowdhury, Corresponding Author Tahseen A. Chowdhury tahseen.chowdhury@nhs.net orcid.org/0000-0001-8878-2331 Department of Diabetes and Metabolism, The Royal London Hospital, London, UK Correspondence Tahseen A. Chowdhury, 7th Floor, John Harrison House. The Royal London Hospital, Whitechapel, London E1 1BB, UK. Email: tahseen.chowdhury@nhs.netSearch for more papers by this author First published: 31 January 2023 https://doi.org/10.1111/dme.15057Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Early ViewOnline Version of Record before inclusion in an issuee15057 RelatedInformation